Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Riverstone Biotech is a synthetic biology company specializing in the sustainable production of high-value natural products through advanced yeast fermentation. The company leverages a proprietary platform to manufacture rare cannabinoids and other complex plant-derived compounds that are traditionally difficult to extract or synthesize. By optimizing metabolic pathways in yeast, Riverstone Bio aims to provide consistent, high-purity, and cost-effective ingredients for the pharmaceutical, wellness, and consumer goods industries. Their approach significantly reduces the environmental footprint associated with traditional agricultural cultivation and chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Riverstone Bio.